Learn More
Medchemexpress LLC Crizotinib (hydrochloride) | 1415560-69-8 | 99.7% | C21H23Cl3FN5O | 1 ML

Supplier: Medchemexpress LLC HY50878A10MM/1ML
Crizotinib hydrochloride is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor. It inhibits tyrosine phosphorylation of NPM-ALK and c-Met in cell-based assays and is also a ROS proto-oncogene 1 (ROS1) inhibitor, demonstrating effective tumor growth inhibition.
- Orally bioavailable
- Selective ALK and c-Met inhibitor
- Inhibits tyrosine phosphorylation of NPM-ALK and c-Met
- Functions as a ROS proto-oncogene 1 (ROS1) inhibitor
- Demonstrates effective tumor growth inhibition
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.